Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel for behavioral symptoms in White-Sutton syndrome
2021-001839-77Phase 2Active
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Nov 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perampanel in White-Sutton syndrome (WHSUS), sponsored by IRCCS Burlo Garofolo. Primary endpoints: Improvement in Child Behavior Checklist and/or Vineland Adaptive Behavior Scales at 6 months, CBCL categorical improvement definition and 1 more. Started Nov 2021; status: active.
02
Drugs
perampanel
03
Conditions
White-Sutton syndrome (WHSUS)
Beyond the preview
Go deeper on 2021-001839-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001839-77.